Dilaudid Injection, Solution
Product Images NDC 76045-009

18 FDA label images from Fresenius Kabi Usa, Llc · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 18 technical images submitted to the FDA as part of the official labeling for Dilaudid (NDC 76045-009). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Fresenius Kabi Usa, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Dil0a 0001 01

Dil0a 0001 01
Chemical structure of hydromorphone hydrochloride, the active ingredient in Dilaudid, shown as a molecular diagram with rings, bonds, and functional groups, including hydroxyl and ketone groups.*
FDA Label Image

Dil0a 0001 02

Dil0a 0001 02
An instructional diagram showing the components of a Dilaudid syringe assembly, including the outer package, tamper-evident seal, tube, cap, label, luer lock collar, plunger rod, syringe barrel, and syringe tip cap. The diagram labels parts and indicates which labels should not be removed.*
FDA Label Image

Dil0a 0001 03

Dil0a 0001 03
An instructional illustration showing hands removing a cap from a syringe. The image demonstrates the proper gripping and twisting motion to open the syringe cap, relevant for the use of injectable products such as Dilaudid.*
FDA Label Image

Dil0a 0001 04

Dil0a 0001 04
An instructional illustration showing hands connecting or assembling two medical device components, likely related to the preparation or administration of Dilaudid solution. The diagram includes an arrow indicating the direction to join the parts.*
FDA Label Image

Dil0a 0001 05

Dil0a 0001 05
An instructional line drawing showing hands holding a syringe and a vial or ampule. The illustration depicts the action of attaching or removing a needle cap, with an arrow indicating the direction of movement.*
FDA Label Image

Dil0a 0001 06

FDA Label Image

Dil0a 0001 07

Dil0a 0001 07
Dilaudid Hydromorphone HCl Injection label showing 0.5 mg per 0.5 mL single-dose vial. The label includes dosing instructions for SC, IM, or slow IV use, and indicates it is for prescription use only. The labeler is Fresenius Kabi USA, LLC, and the label features a barcode and NDC code.*
FDA Label Image

Dil0a 0001 08

Dil0a 0001 08
Dilaudid 0.5 mg per 0.5 mL HYDROmorphone HCl Injection, USP label for a 0.5 mL single-dose prefilled syringe. The label includes storage instructions (20° to 25°C), caution against diluting for IV push, and usage for subcutaneous, IM, or slow IV use. The labeler is Fresenius Kabi USA, LLC.*
FDA Label Image

Dil0a 0001 09

Dil0a 0001 09
Packaging label for Dilaudid 0.5 mg per 0.5 mL Injection USP by Fresenius Kabi USA, LLC. The label is for HYDROmorphone HCl injection in prefilled syringes. Each box contains 10 single-dose 0.5 mL syringes. The label indicates use for subcutaneous, intramuscular, or slow intravenous injection and includes storage and handling instructions.*
FDA Label Image

Dil0a 0001 10

Dil0a 0001 10
Label for Dilaudid Hydromorphone HCl Injection, USP, with concentration 0.2 mg/mL. The label indicates use for SC, IM, or slow IV administration and denotes a 1 mL single-dose vial. It includes a measurement scale up to 1 mL and shows the labeler as Fresenius Kabi USA, LLC.*
FDA Label Image

Dil0a 0001 11

Dil0a 0001 11
Label for Dilaudid Hydromorphone HCl Injection, USP 0.2 mg/mL in a 1 mL single-dose prefilled syringe by Fresenius Kabi USA, LLC. The label includes storage instructions and warnings not to dilute for IV push or place the syringe on a sterile field. It also notes use for subcutaneous, intramuscular, or slow intravenous administration.*
FDA Label Image

Dil0a 0001 12

Dil0a 0001 12
Packaging label for Dilaudid 0.2 mg/mL Hydro morphone HCl Injection, USP by Fresenius Kabi USA, LLC. The label indicates use for subcutaneous, intramuscular, or slow intravenous administration. The package contains 10 single-dose prefilled 1 mL syringes. Storage and usage instructions include not diluting for IV push and not placing the syringe on a sterile field.*
FDA Label Image

Dil0a 0001 13

Dil0a 0001 13
Dilaudid 1 mg/mL injection label showing hydromorphone HCl for subcutaneous, intramuscular, or slow intravenous use. The label includes a 1 mL single-dose mark, prescription only notation, and is labeled by Fresenius Kabi USA, LLC. Barcode and quantity information are also present.*
FDA Label Image

Dil0a 0001 14

Dil0a 0001 14
Dilaudid 1 mg/mL Hydromorphone HCl Injection, USP label for a 1 mL single-dose prefilled syringe by Fresenius Kabi USA, LLC. Instructions include storage at 20° to 25°C, protection from light, and use warnings such as not diluting for IV push or placing the syringe on a sterile field. Suitable for subcutaneous, intramuscular, or slow intravenous use.*
FDA Label Image

Dil0a 0001 15

Dil0a 0001 15
Packaging label for Dilaudid 1 mg/mL injection, USP by Fresenius Kabi USA, LLC. The label is for 10 single-dose prefilled syringes of 1 mL each, containing hydromorphone hydrochloride, for subcutaneous, intramuscular, or slow intravenous use. It includes usage warnings, storage instructions, and the NDC 76045-009-11.*
FDA Label Image

Dil0a 0001 16

Dil0a 0001 16
Label for Dilaudid Hydromorphone HCl Injection, USP, 2 mg/mL, by Fresenius Kabi USA, LLC. The label includes a measurement scale with markings at 0.5 mL and 1 mL, indicating single-dose use for SC, IM, or slow IV administration.*
FDA Label Image

Dil0a 0001 17

Dil0a 0001 17
Label for Dilaudid hydromorphone HCl injection USP, 2 mg/mL in a 1 mL single-dose prefilled syringe. The label includes storage instructions, usage routes (subcutaneous, intramuscular, or slow intravenous), and cautions against dilution and placing the syringe on a sterile field. Labeler is Fresenius Kabi USA, LLC.*
FDA Label Image

Dil0a 0001 18

Dil0a 0001 18
Dilaudid 2 mg/mL injection carton label showing HYDROmorphone HCl Injection, USP. The package contains 10 single-dose 1 mL prefilled syringes. Labeled for subcutaneous, intramuscular, or slow intravenous use. The labeler is Fresenius Kabi USA, LLC and the NDC is 76045-010-11. The label includes storage and usage instructions and warnings against intrathecal or epidural use.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.